CVS Removes Ineffective Decongestants from Shelves

October 20, 2023: CVS Health has announced removing certain decongestant products from its shelves and discontinuing sales. The decision follows a recommendation from an advisory panel to the US Food and Drug Administration (FDA) that the decongestant ingredient phenylephrine is ineffective when taken orally.

Phenylephrine is a common ingredient in many over-the-counter decongestant products. It works by narrowing blood vessels in the nose, which can help reduce inflammation and swelling. However, the FDA advisory panel found insufficient evidence to support the claim that phenylephrine is effective when taken orally.

CVS Health is taking the precautionary step of removing all oral decongestant products that contain phenylephrine from its shelves. The company also recommends that consumers talk to their doctor about other options for relieving nasal congestion.

The FDA has yet to decide on the status of phenylephrine in over-the-counter decongestants. However, the agency is reviewing the evidence and may take action.